Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7472 p375
6 October 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Academic super-trust for London

John Alex Maguire/ex Features

Charing Cross Hospital

Charing Cross Hospital and four others are to form a single trust and seek academic foundation status

Imperial College London is to be at the helm of a new NHS super-trust, following the union of two of London's largest hospitals this week. Hammersmith Hospitals NHS Trust and St Mary's NHS Trust have merged, and existing links with Imperial College have been strengthened, to form Imperial College Healthcare NHS Trust.

The new trust will operate Charing Cross Hospital, Hammersmith Hospital, Queen Charlotte’s and Chelsea Hospital, St Mary’s Hospital and the Western Eye Hospital.

In terms of the impact of the merger on pharmacy services, a spokeswoman for the trust said that no decisions had been made about management at the departmental level, but she acknowledged that decisions would need to be made.

“It will definitely be one of the largest pharmacy departments in the country, with an expenditure of over £70m and around 250 staff,” she told The Journal. “Because it is the first academic health science centre of its kind in the UK, there will be advantages for staff in terms of practice-based research.”

She explained that the principal of the faculty of medicine at Imperial College, Stephen Smith, has been appointed chief executive of the trust, a move that she said would integrate academia into NHS trust management structures at the top level.

“This will reduce the bureaucracy around how innovation feeds into hospital practice,” she said.

It is expected that Imperial College will sponsor an application for the centre to become an “academic foundation trust” in 2009, subject to consultation.

Back to Top


©The Pharmaceutical Journal